Clinical Focus

  • Anesthesiology

Academic Appointments

  • Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

Professional Education

  • Board Certification: American Board of Anesthesiology, Anesthesiology (2023)
  • Fellowship: Stanford University Anesthesiology Fellowships (2023) CA
  • Residency: Stanford University Anesthesiology Residency (2022) CA
  • Internship: Stanford University Internal Medicine Residency (2019) CA
  • Medical Education: Stanford University School of Medicine (2018) CA

Contact

  • Academic
    University - Academic staff Department: Anesthesia - Cardiac Position: Clinical Assistant Professor
  • Clinical (Primary)  Anesthesia 300 Pasteur Dr Rm H2512 MC 5637 Stanford, CA 94304 (650) 725-8544 (fax)

Additional Clinical Info

Additional Info

  • Mail Code: 5640

All Publications

  • Beating Heart Transplants-Overview and Implications for Anesthesiologists. Journal of cardiothoracic and vascular anesthesia Kothari, P., Kiwakyou, L. M., Guenthart, B. A., Vanneman, M. 2023

    Abstract

    As the demand for heart allografts for transplantation continues to rise, ex vivo organ perfusion strategies are playing an increasingly important role in the preservation of organs from donation after circulatory death and extended-criteria donors. One such method uses the Organ Care System (TransMedics, Andover, MA). Traditionally, this technique of preservation requires 2 periods of warm ischemia and subsequent cardioplegic arrest. In a novel surgical technique pioneered at the authors' institution, heart allograft implantation no longer requires a second cardioplegic arrest. This article discusses the surgical approach for this procedure, the advantages and disadvantages of this approach, and analogs to current clinical practice to theorize what impact this may have on cardiac transplantation volumes in the future.

    View details for DOI 10.1053/j.jvca.2023.12.031

    View details for PubMedID 38228423

  • Highlights and Perioperative Implications from the 2022 American College of Cardiology and American Heart Association Guidelines for Diagnosis and Management of Aortic Disease. Journal of cardiothoracic and vascular anesthesia Kothari, P., Bodmer, N. J., Ellis, S., Kiwakyou, L. M., Choi, C. 2023

    Abstract

    As the understanding of aortic diseases and their complications grow, increasing importance of uniformity in diagnosis and management is crucial for optimal care of this patient population. The 2022 American College of Cardiology and American Heart Association Guidelines for Diagnosis and Management of Aortic Disease discusses these considerations in detail. The purpose of this review is to highlight essential recommendations that are of relevance to the perioperative physician who manages these patients. A few notable points include, shared decision-making with patients, creation of multidisciplinary aortic teams, lower diameter thresholds for surgery in certain situations, and increased testing for patients with heritable aortic diseases. In addition to briefly reviewing basics of aortic diseases, the authors discuss changes to guidelines that are especially relevant to perioperative care.

    View details for DOI 10.1053/j.jvca.2023.05.037

    View details for PubMedID 37353422

  • Buprenorphine and Cardiac Surgery: Navigating the Challenges of Pain Management. Journal of cardiothoracic and vascular anesthesia Fernando, R. J., Graulein, D., Hamzi, R. I., Augoustides, J. G., Khalil, S., Sanders, J., Sibai, N., Hong, T. S., Kiwakyou, L. M., Brodt, J. L. 2022

    View details for DOI 10.1053/j.jvca.2022.04.050

    View details for PubMedID 35667956

  • What's in a Word? Qualitative and Quantitative Analysis of Leadership Language in Anesthesiology Resident Feedback Journal of Graduate Medical Education Arking, N., Lai, C., Kiwakyou, L. M., Lochbaum, G. M., Shafer, A., Howard, S. K., Mariano, E. R., Fassiotto, M. 2019; 11 (1): 44-52

    View details for DOI 10.4300/JGME-D-18-00377.1

  • X-ray triggered release of doxorubicin from nanoparticle drug carriers for cancer therapy. Chemical communications (Cambridge, England) Starkewolf, Z. B., Miyachi, L., Wong, J., Guo, T. 2013; 49 (25): 2545-7

    Abstract

    Enhanced cellular toxicity was observed using X-ray irradiated nanoparticle drug carriers (NDC) consisting of doxorubicin (DOX) conjugated to DNA strands attached to the surface of gold nanoparticles. Kinetic studies showed that X-rays, acting as a triggering modality, generated reactive oxygen species to break DNA strands and release DOX.

    View details for DOI 10.1039/c3cc38100e

    View details for PubMedID 23423224